BioSpace News Archive

£1.25 million already secured based on pre-money valuation of £18.2 million

DEA rescheduling of Epidiolex to Schedule V establishes commercial viability for cannabis-based formulations

Mesoblast Limited today announced that the 159-patient randomized placebo-controlled Phase 2b trial evaluating its allogeneic mesenchymal precursor cell (MPC) product candidate MPC-150-IM in the treatment of end-stage heart failure patients implanted with a left ventricular assist device (LVAD) has been selected as a late-breaking presentation at the 2018 Scientific Sessions of the American Heart Association being held in Chicago from November 11-13.

Both studies also showed greater reductions in glucose excursions after mealtime

CathVision ApS announced today that the company received ISO 13485:2016 certification for Medical Device and Quality Management Systems from Lloyd’s Register.

Based on its interview with Dr. Leslie Norins, CEO of Alzheimer’s Germ Quest, Inc., Contagion, a newsmagazine for infectious disease specialists indicated the “germ theory” of Alzheimer’s disease causation was gaining traction.

Health care company receives multiple awards for its programs that promote teammate well-being and improve candidates’ experience

New Miami Kit-Building Facility Serves the Americas: Completes Global Network

The Tauri Group Inc. was recently awarded a contract supporting United States Army Medical Materiel Agency (USAMMA) with a ceiling value of nearly $70 million.

Kurin Inc. announced today that it has been awarded a Med/Surg Group agreement in the Safety Phlebotomy Category with Premier.